cfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infections in general practice: a study protocol for a prospective cohort study

INTRODUCTION: The clinical course of patients with a SARS-CoV-2 (COVID-19) infection varies widely, from symptom-free to severe courses that can lead to death. Laboratory values of SARS-CoV-2 patients such as lymphocyte counts or C-reactive protein (CRP) do not allow a prediction of the actual cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehnen, Dorothea, Neuberger, Elmo, in der Schmitten, Jürgen, Giagkou, Ekaterini, Simon, Perikles, Botzenhardt, Suzan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
General practice / Family practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207575/
https://www.ncbi.nlm.nih.gov/pubmed/35710258
http://dx.doi.org/10.1136/bmjopen-2021-058647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207575/
https://www.ncbi.nlm.nih.gov/pubmed/35710258
http://dx.doi.org/10.1136/bmjopen-2021-058647

Ejemplares similares